Publications by authors named "Alberto Montero"

Claim this Profile
D
Deconstructing racial disparities in timely treatment of triple-negative breast cancer: A causal mediation analysis.
Trisha Lal, Richard S Hoehn, Alberto J Montero, Amanda L Amin

Am J Surg· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whose Autonomy Matters? Using Relational Autonomy to Analyze Caregiver Roles in Decision-Making for Cancer Clinical Trials.
Eric C Blackstone, Susan R Mazanec, Barbara J Daly, Jennifer A Dorth, Alberto J Montero

AJOB Empir Bioeth· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Review of Current Literature and Real-World Outcomes With Neoadjuvant Chemotherapy in Hormone Receptor Positive, HER2 Negative Breast Cancer.
Gregory Guzik, Matthew Kurian, Kanchi Patell, Marcus Trybula, Pingfu Fu, Alberto Montero

Clin Breast Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Randomized Study of Paclitaxel Alone or Combined with Pelareorep with or without Avelumab in Metastatic Hormone Receptor-Positive Breast Cancer: The BRACELET-01/PrE0113 Study.
Amy S Clark, Fengmin Zhao, Paula Klein, Alberto J Montero, Carla Falkson

Clin Cancer Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stakeholder perspectives on the role of caregivers in cancer clinical trial decision-making: results of a qualitative study.
Eric C Blackstone, Susan R Mazanec, Barbara J Daly, Jennifer A Dorth, Alberto J Montero

Support Care Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Responses to checkpoint inhibition in metastatic triple negative breast cancer driven by divergent myeloid phenotypes.
Avia D Wilkerson, Ivan Juric, Salendra Singh, Patricia A Rayman, Paul G Pavicic, Alberto J Montero, C Marcela Diaz-Montero

Commun Med (Lond)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing breast cancer treatment outcomes between fee-for-service and Medicare Advantage.
Galen Shearn-Nance, Rishi R Sachdev, Long Vu, Weichuan Dong, Alberto J Montero

Am J Manag Care· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MELK as a Mediator of Stemness and Metastasis in Aggressive Subtypes of Breast Cancer.
Breanna McBean, Reine Abou Zeidane, Samuel Lichtman-Mikol, Benjamin Hauk, Johnathan Speers, Alberto Montero

Int J Mol Sci· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel machine learning-based cancer-specific cardiovascular disease risk score among patients with breast, colorectal, or lung cancer.
Nickolas Stabellini, Omar M Makram, Harikrishnan Hyma Kunhiraman, Hisham Daoud, John Shanahan, Alberto J Montero

JNCI Cancer Spectr· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse social determinants of health elevate uncontrolled hypertension risk: a cardio-oncology prospective cohort study.
Priyanshu Nain, Nickolas Stabellini, Omar M Makram, Johnathan Rast, Sandeep Yerraguntla, Alberto J Montero

JNCI Cancer Spectr· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allostatic Load/Chronic Stress and Cardiovascular Outcomes in Patients Diagnosed With Breast, Lung, or Colorectal Cancer.
Nickolas Stabellini, Jennifer Cullen, Marcio S Bittencourt, Justin X Moore, Arnethea Sutton, Alberto J Montero

J Am Heart Assoc· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study.
Miguel Martín, Elgene Lim, Mariana Chavez-MacGregor, Aditya Bardia, Jiong Wu, Alberto J Montero

J Clin Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer.
Samuel A Jacobs, Ying Wang, Jame Abraham, Huichen Feng, Alberto J Montero

Breast Cancer Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer.
Samuel A Jacobs, Ying Wang, Jame Abraham, Huichen Feng, Alberto J Montero

Breast Cancer Res· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Neuroendocrine Breast Carcinoma (NEBC): Review of Literature.
A Mohamed, J Zeidalkilani, S L Asa, M Trybula, Alberto J Montero

Oncol Rev· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer.
Avia D Wilkerson, Prerana Bangalore Parthasarathy, Nickolas Stabellini, Carley Mitchell, Paul G Pavicic, C Marcela Diaz-Montero, Alberto J Montero

Clin Cancer Res· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating the overall survival benefit of adjuvant chemo-endocrine therapy in women over age 50 with pT1-2N0 early stage breast cancer and 21-gene recurrence score ≥26: A National Cancer Database analysis.
Nickolas Stabellini, Lifen Cao, Christopher W Towe, Amanda L Amin, Alberto J Montero

Cancer Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the PREDICT Prognostication Tool in US Patients With Breast Cancer.
Nickolas Stabellini, Lifen Cao, Christopher W Towe, Megan E Miller, Artur H Sousa-Santos, Alberto J Montero

J Natl Compr Canc Netw· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Social Determinants of Health Data Improve the Prediction of Cardiac Outcomes in Females with Breast Cancer.
Nickolas Stabellini, Jennifer Cullen, Justin X Moore, Susan Dent, Arnethea L Sutton, Alberto J Montero

Cancers (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiomic predicts early response to CDK4/6 inhibitors in hormone receptor positive metastatic breast cancer.
Mohammadhadi Khorrami, Vidya Sakar Viswanathan, Priyanka Reddy, Nathaniel Braman, Siddharth Kunte, Alberto J Montero

NPJ Breast Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Social Determinants of Health and Racial Disparities in Cardiac Events in Breast Cancer.
Nickolas Stabellini, Mantas Dmukauskas, Marcio S Bittencourt, Jennifer Cullen, Amie J Barda, Alberto J Montero

J Natl Compr Canc Netw· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thirty-Day Unplanned Hospital Readmissions in Patients With Cancer and the Impact of Social Determinants of Health: A Machine Learning Approach.
Nickolas Stabellini, Aziz Nazha, Nikita Agrawal, Merilys Huhn, John Shanahan, Alberto J Montero

JCO Clin Cancer Inform· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival in elderly patients with breast cancer with and without autoimmune disease.
Demitrios Dedousis, Annie L Zhang, Anastasia N Vassiliou, Shufen Cao, Deepthi Yammani, Alberto J Montero

Cancer Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant chemotherapy is associated with an overall survival benefit regardless of age in ER+/HER2- breast cancer pts with 1-3 positive nodes and oncotype DX recurrence score 20 to 25: an NCDB analysis.
Nickolas Stabellini, Lifen Cao, Christopher W Towe, Xun Luo, Amanda L Amin, Alberto J Montero

Front Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial Differences in Chronic Stress/Allostatic Load Variation Due to Androgen Deprivation Therapy in Prostate Cancer.
Nickolas Stabellini, Jennifer Cullen, Justin X Moore, Lifen Cao, Neeraj Agarwal, Alberto J Montero

JACC CardioOncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis